425 related articles for article (PubMed ID: 18391787)
1. Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis.
Perez-Pinera P; Berenson JR; Deuel TF
Curr Opin Hematol; 2008 May; 15(3):210-4. PubMed ID: 18391787
[TBL] [Abstract][Full Text] [Related]
2. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
[TBL] [Abstract][Full Text] [Related]
3. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway.
Deuel TF; Zhang N; Yeh HJ; Silos-Santiago I; Wang ZY
Arch Biochem Biophys; 2002 Jan; 397(2):162-71. PubMed ID: 11795867
[TBL] [Abstract][Full Text] [Related]
4. Pleiotrophin induces formation of functional neovasculature in vivo.
Christman KL; Fang Q; Kim AJ; Sievers RE; Fok HH; Candia AF; Colley KJ; Herradon G; Ezquerra L; Deuel TF; Lee RJ
Biochem Biophys Res Commun; 2005 Jul; 332(4):1146-52. PubMed ID: 15949466
[TBL] [Abstract][Full Text] [Related]
5. Redox signaling in angiogenesis: role of NADPH oxidase.
Ushio-Fukai M
Cardiovasc Res; 2006 Jul; 71(2):226-35. PubMed ID: 16781692
[TBL] [Abstract][Full Text] [Related]
6. Heparin-binding protein pleiotrophin: an important player in the angiogenic process.
Mikelis C; Papadimitriou E
Connect Tissue Res; 2008; 49(3):149-52. PubMed ID: 18661331
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin stimulates angiogenesis and human endothelial cell migration through the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta.
Koutsioumpa M; Hatziapostolou M; Mikelis C; Koolwijk P; Papadimitriou E
Eur J Pharmacol; 2009 Jan; 602(2-3):245-9. PubMed ID: 19059395
[TBL] [Abstract][Full Text] [Related]
9. A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.
Mikelis C; Lamprou M; Koutsioumpa M; Koutsioubas AG; Spyranti Z; Zompra AA; Spiliopoulos N; Vradis AA; Katsoris P; Spyroulias GA; Cordopatis P; Courty J; Papadimitriou E
J Cell Biochem; 2011 Jun; 112(6):1532-43. PubMed ID: 21344482
[TBL] [Abstract][Full Text] [Related]
10. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.
Choudhuri R; Zhang HT; Donnini S; Ziche M; Bicknell R
Cancer Res; 1997 May; 57(9):1814-9. PubMed ID: 9135027
[TBL] [Abstract][Full Text] [Related]
11. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H
Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659
[TBL] [Abstract][Full Text] [Related]
12. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides.
Papadimitriou E; Polykratis A; Courty J; Koolwijk P; Heroult M; Katsoris P
Biochem Biophys Res Commun; 2001 Mar; 282(1):306-13. PubMed ID: 11264008
[TBL] [Abstract][Full Text] [Related]
13. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.
Perez-Pinera P; Chang Y; Deuel TF
Cell Cycle; 2007 Dec; 6(23):2877-83. PubMed ID: 18156802
[TBL] [Abstract][Full Text] [Related]
14. The BTB-Kelch protein KLEIP controls endothelial migration and sprouting angiogenesis.
Nacak TG; Alajati A; Leptien K; Fulda C; Weber H; Miki T; Czepluch FS; Waltenberger J; Wieland T; Augustin HG; Kroll J
Circ Res; 2007 Apr; 100(8):1155-63. PubMed ID: 17395875
[TBL] [Abstract][Full Text] [Related]
15. Pleiotrophin and midkine in normal development and tumor biology.
Kurtz A; Schulte AM; Wellstein A
Crit Rev Oncog; 1995; 6(2):151-77. PubMed ID: 8792088
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor as an angiogenic factor.
Nico B; Mangieri D; Benagiano V; Crivellato E; Ribatti D
Microvasc Res; 2008 Mar; 75(2):135-41. PubMed ID: 17764704
[TBL] [Abstract][Full Text] [Related]
17. Regulators of angiogenesis and strategies for their therapeutic manipulation.
Milkiewicz M; Ispanovic E; Doyle JL; Haas TL
Int J Biochem Cell Biol; 2006 Mar; 38(3):333-57. PubMed ID: 16309946
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor and angiogenesis.
Hoeben A; Landuyt B; Highley MS; Wildiers H; Van Oosterom AT; De Bruijn EA
Pharmacol Rev; 2004 Dec; 56(4):549-80. PubMed ID: 15602010
[TBL] [Abstract][Full Text] [Related]
19. STAT3: a critical transcription activator in angiogenesis.
Chen Z; Han ZC
Med Res Rev; 2008 Mar; 28(2):185-200. PubMed ID: 17457812
[TBL] [Abstract][Full Text] [Related]
20. Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer.
Papadimitriou E; Pantazaka E; Castana P; Tsalios T; Polyzos A; Beis D
Biochim Biophys Acta; 2016 Dec; 1866(2):252-265. PubMed ID: 27693125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
